Literature DB >> 17331531

Purification and HPLC-MS analysis of a naturally processed HCMV-derived peptide isolated from the HEK-293T/HLA-E+/Ul40+ cell transfectants and presented at the cell surface in the context of HLA-E.

E Millo1, G Pietra, A Armirotti, P Vacca, M C Mingari, L Moretta, G Damonte.   

Abstract

A new method for isolation and characterization of peptides presented in the context of the nonclassical human leukocytes antigen (HLA) class I molecule HLA-E was developed. A combination of different chromatographic steps coupled with electrospray mass spectrometry allowed us to detect the presence of small amounts of a naturally processed human Cytomegalovirus (HCMV)-derived peptide isolated from the HEK-293T/HLA-E+/UL40+ transfected cells of from HELA cell line. The peptide sequence was confirmed by tandem mass spectrometry (MS/MS). This approach provides a versatile and sensitive method for direct identification of MHC class I-binding peptides that might be derive from different pathogen or tumor-associated proteins.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17331531     DOI: 10.1016/j.jim.2007.01.018

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  Human cytomegalovirus UL40 signal peptide regulates cell surface expression of the NK cell ligands HLA-E and gpUL18.

Authors:  Virginie Prod'homme; Peter Tomasec; Charles Cunningham; Marius K Lemberg; Richard J Stanton; Brian P McSharry; Eddie C Y Wang; Simone Cuff; Bruno Martoglio; Andrew J Davison; Véronique M Braud; Gavin W G Wilkinson
Journal:  J Immunol       Date:  2012-02-15       Impact factor: 5.422

2.  HLA-C increases HIV-1 infectivity and is associated with gp120.

Authors:  Andrea Matucci; Paola Rossolillo; Miriam Baroni; Antonio G Siccardi; Alberto Beretta; Donato Zipeto
Journal:  Retrovirology       Date:  2008-08-01       Impact factor: 4.602

Review 3.  Natural killer cells in herpesvirus infections.

Authors:  Christian Münz; Obinna Chijioke
Journal:  F1000Res       Date:  2017-07-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.